about
Mechanisms of islet amyloidosis toxicity in type 2 diabetesAmyloidosis: a convoluted storyStructural basis for the recognition and cross-linking of amyloid fibrils by human apolipoprotein EMethylated BSA mimics amyloid-related proteins and triggers inflammationExamining serum amyloid P component microheterogeneity using capillary isoelectric focusing and MALDI-MSC-reactive protein is essential for innate resistance to pneumococcal infection.The relation of proteoglycans, serum amyloid P and apo E to amyloidosis current status, 2000.Antibodies to human serum amyloid P component eliminate visceral amyloid deposits.Cutis laxa in hereditary gelsolin amyloidosis.Target Mediated Drug Disposition Model of CPHPC in Patients with Systemic AmyloidosisC-reactive protein and cardiovascular disease: new insights from an old molecule.Brain serum amyloid P levels are reduced in individuals that lack dementia while having Alzheimer's disease neuropathology.FcγRI mediates serum amyloid P inhibition of fibrocyte differentiationDrug Insight: emerging therapies for amyloidosis.Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits in vivoAmyloidosis and the lung.In vivo supramolecular templating enhances the activity of multivalent ligands: a potential therapeutic against the Escherichia coli O157 AB5 toxins.Multifaceted anti-amyloidogenic and pro-amyloidogenic effects of C-reactive protein and serum amyloid P component in vitro.2A4 binds soluble and insoluble light chain aggregates from AL amyloidosis patients and promotes clearance of amyloid deposits by phagocytosis †.Pathophysiology and treatment of systemic amyloidosis.How to diagnose amyloidosis.Insulin amyloid at injection sites of patients with diabetes.Cross-interactions between the Alzheimer Disease Amyloid-β Peptide and Other Amyloid Proteins: A Further Aspect of the Amyloid Cascade Hypothesis.S100A6 amyloid fibril formation is calcium-modulated and enhances superoxide dismutase-1 (SOD1) aggregation.Spontaneous, Experimentally Induced, and Transmissible AA Amyloidosis in Japanese Quail ( Coturnix japonica).Abdominal CT findings in nephropathic amyloidosis of familial Mediterranean fever.Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis.Extension of A beta2M amyloid fibrils with recombinant human beta2-microglobulin.Immunohistochemical characterization of novel monoclonal antibodies against the N-terminus of amyloid β-peptide.Serum amyloid P component in mink, a non-glycosylated protein with affinity for phosphorylethanolamine and phosphorylcholine.Sustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosis.Human TTRV30M localization within podocytes in a transgenic mouse model of transthyretin related amyloidosis: does the environment play a role?Immunohistochemical identification of amyloid, using an anti-human serum amyloid P component (SAP) antibody, is possible in ruminants but not in dogs and cats.In vitro binding of [³H]PIB to human amyloid deposits of different types.Ligand-assisted aggregation of proteins. Dimerization of serum amyloid P component by bivalent ligands.Splenic ellipsoids: an early target for deposition of AA amyloid induced in mink.Antiamyloidogenic and proamyloidogenic chaperone effects of C-reactive protein and serum amyloid P component.Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.Quantitative high-resolution microradiographic imaging of amyloid deposits in a novel murine model of AA amyloidosis.
P2860
Q26823708-C093441D-0471-4FAC-A34D-1D7E41D7FC6BQ28215995-CA9A2D22-6F57-4785-9E21-36E65B526F5EQ28252183-45746480-06F0-48BD-B1BA-B774CD05E5EDQ28487451-70703146-66B8-4C4B-A5F8-D10B0E953B5FQ33779346-D34FE2E1-4DE0-4C03-9748-0C1A81243CD2Q33842663-98533BF1-839D-48FF-B1A6-25A99C9B67DBQ33937070-90F04B3C-6E1B-4B73-8B45-43EA8A6226C6Q34144814-052A6A70-20DC-415A-81C4-21FFD5213EF5Q34396968-B335582B-36C5-4C2C-8303-5D7FC82D52D7Q35179540-E00A3541-7CC2-4E42-95DB-BD476BF6F617Q35562701-917719D5-FD29-419D-B8AD-72F397F128BDQ35823366-6182B065-1594-430C-803C-88A048F95A38Q36232242-6AE7F162-51D6-4CB7-B6CC-FFF4B69F8DD6Q36577160-6D386D3E-2B44-46B5-83DF-227850B0B734Q36635583-DCCE2931-FB1F-4EFA-8E58-6DBBE430D68DQ36692876-21C6F30E-0037-4272-9D17-DB01D9027DBCQ36950791-02F88B59-56D9-40EF-80D8-7E2D1BFCFBC9Q37067700-E2751728-CFFD-41B7-8B9C-046801310A3BQ37494829-55905B4D-A655-49A2-A30C-F061D6E8AF38Q38131710-F224E580-9337-45B7-B591-2EB44434BB0FQ38136289-78BDED9A-0C41-489B-8D1D-EC85CEB22A50Q38829576-79C65B58-5639-42DB-9FF4-1E4452EF96CEQ38871578-775AED56-202A-4DBA-B4AF-7F9F64E7E113Q39257498-090E86A0-9785-43C3-B58C-B81A7DD1915EQ40091667-4FE7438A-A477-4330-8272-AA658873F7A5Q40604912-972EC5CA-8FAF-4ECE-B496-12E540CB8174Q43075090-27C9DC3A-A408-4944-B1A3-F7F1B412E932Q43568860-19D8C2C9-FAAE-4C77-922B-C1E237C60D18Q44640299-3F07016A-CF6F-4979-9657-618953D8CA87Q45102163-EF608B8E-26CD-483B-A538-EDD9DC4E71FFQ45825222-98A4407E-895C-4D89-B385-7F68BB2B343DQ45967429-079FEB9F-E18A-46FC-B91C-2D64C0F6FAA4Q46210429-36DC685F-BC8E-46BC-A4CB-41D50412AF97Q46222348-67188E00-DE1A-4991-A290-89FDA6033D13Q46612865-D9BB64BB-CA2F-43C5-AFF4-89427267D673Q48031959-846B93B1-C701-4E79-B32D-23236BBFC511Q51039665-CF774016-3668-45D3-A864-3B8DABBFAAC6Q52957195-A3EB532F-AD8B-467B-9BE0-C01755466BA6Q53568258-F9F51DF0-C9CC-493A-B3CF-9D6B333195F4
P2860
description
article
@en
im Januar 1997 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 1997
@uk
ലേഖനം
@ml
name
Amyloid P component. A critical review
@en
Amyloid P component. A critical review
@nl
type
label
Amyloid P component. A critical review
@en
Amyloid P component. A critical review
@nl
prefLabel
Amyloid P component. A critical review
@en
Amyloid P component. A critical review
@nl
P2093
P2860
P1433
P1476
Amyloid P component. A critical review
@en
P2093
D. R. Booth
E. Hohenester
I. M. Collins
J. R. Gallimore
M B. Pepys
W. L. Hutchinson
P2860
P304
P356
10.3109/13506129709003838
P577
1997-01-01T00:00:00Z